Turn Medical
San Antonio, US · Founded 2018 · Texas LLC
Turn Medical develops and manufactures the Pronova-O2 Automated Prone Therapy System, a medical device for repositioning critically ill patients to improve patient outcomes and caregiver safety. The company serves clinicians, hospitals, and clinical institutions.
Founders & leadership
CN
Chris NiederkrominManager
TP
Tara PsencikNamed on SEC filing
KW
Kevin WilsonManager
EB
Eric BartaManager
Reported raises · per SEC filings
Form D private placements$13.5M disclosed across 5 rounds · 2021–2024
▶$4.7MraisedApr 2024 · 1 investors · BiotechnologyRule 506(b)
▶$4.7MraisedApr 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian StraebDirector
- Tara PsencikExecutive Officer, Director
- Chris NiederkromExecutive Officer, Director
- Larry J. MillerDirector
- Gary KnippaDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- Minimum investment
- $1.7M
- First sale
- Apr 2024
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$1MraisedApr 2024 · 4 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary KnippaDirector
- Larry J. MillerDirector
- Chris NiederkromExecutive Officer, Director
- Brian StraebDirector
- Tara PsencikExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $65K
- First sale
- Jul 2023
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$3.8MraisedFeb 2022 · BiotechnologyRule 506(b)
▶$3.8MraisedFeb 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry J. MillerDirector
- Chris NiederkromExecutive Officer, Director
- Brian StraebDirector
- Kevin WilsonExecutive Officer, Director
- Eric BartaExecutive Officer, Director
- Tara PsencikExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- Minimum investment
- $3.8M
- Proceeds to insiders
- $200K
- First sale
- Feb 2022
- Incorporated
- Limited Liability Company, Texas, 2018
- Federal exemptions
- 06b
▶$2.4MraisedSep 2021 · 8 investors · Other Health CareRule 506(b)
▶$2.4MraisedSep 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin WilsonExecutive Officer, Director
- Eric BartaExecutive Officer, Director
- Tara PsencikExecutive Officer, Director
- Chris NiederkromExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $50K
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Texas, 2018
- Federal exemptions
- 06b
▶$1.5MraisedApr 2021 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedApr 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin WilsonExecutive Officer, Director
- Eric BartaExecutive Officer, Director
- Tara PsencikExecutive Officer
- Chris NiederkromExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $500K
- Proceeds to insiders
- $100K
- First sale
- Jan 2021
- Incorporated
- Limited Liability Company, Texas, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Turn Medical do?
- Turn Medical develops and manufactures the Pronova-O2 Automated Prone Therapy System, a medical device for repositioning critically ill patients to improve patient outcomes and caregiver safety. The company serves clinicians, hospitals, and clinical institutions.
- How much funding has Turn Medical raised?
- Turn Medical has disclosed $13.5M raised across 5 rounds.
- Where is Turn Medical headquartered?
- Turn Medical is headquartered in San Antonio, US.